Comments

Cue Biopharma Insider Trading Activity

CUENASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$0.3951

-0.0049-1.23%

Last update: Dec 18, 11:14 AM

Overview News Earnings Options Analyst Ratings

Insider Trades

Short Interest Stock Report

Cue Biopharma Insider Trading Activity | NASDAQ:CUE | Benzinga

Track the latest Cue Biopharma insider trading activity. Stay informed on recent buys, sells, and market impact for Cue Biopharma stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Cue Biopharma Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Cue Biopharma Inc

Shares Outstanding

78.738M

Insider Shares Owned

2.218M

Insider Percentage Owned

2.82%

Institutional Shares Held

4.440M

Institutional Percentage Held

5.64%


Dec 18, 2024	Daniel Passeri	CHIEF EXECUTIVE OFFICER	30.00K	$1.03	$30.90K	BUY	22.29%	164.58K	Dec 16	View
Aug 29, 2023	Anish Suri	PRESIDENT AND CSO	4.00K	$2.76	$11.04K	BUY	3.04%	135.64K	Aug 25	View
Aug 16, 2023	Daniel Passeri	CHIEF EXECUTIVE OFFICER	3.00K	$2.86	$8.58K	BUY	2.28%	134.58K	Aug 14	View
Mar 27, 2023	Peter Kiener	DIRECTOR	357.00	$3.07	-$2.90K	SELL-OPTIONS	∞	357.00	Mar 23	View
May 31, 2022	Frank Morich	DIRECTOR	28.00K	$3.75	$105.00K	BUY	∞	28.00K	May 27	View
May 25, 2022	Aaron Fletcher	DIRECTOR	205.00K	$3.47	$711.70K	BUY	27.56%	948.87K	May 23 - May 24	View
Apr 04, 2022	Aaron Fletcher	DIRECTOR	735.00K	$4.76	$3.50M	BUY	8289.16%	743.87K	Mar 31	View
Nov 17, 2021	Peter Kiener	DIRECTOR	0.00	$10.39	-$303.99K	SELL-OPTIONS	0.00%	0.00	Nov 15 - Nov 16	View
Nov 17, 2021	Anish Suri	PRESIDENT AND CSO	0.00	$13.16	-$78.32K	SELL-OPTIONS	0.00%	94.04K	Nov 15	View
Nov 15, 2021	Anish Suri	PRESIDENT AND CSO	0.00	$10.74	-$172.95K	SELL-OPTIONS	0.00%	94.04K	Nov 11	View
Oct 05, 2021	Kerri-Ann Millar	CHIEF FINANCIAL OFFICER	4.71K	$10.86	-$8.40K	SELL-OPTIONS	81.62%	10.47K	Aug 23 - Oct 01	View
Sep 27, 2021	Anish Suri	PRESIDENT AND CSO	0.00	$10.83	-$176.25K	SELL-OPTIONS	0.00%	74.84K	Sep 23	View
Sep 27, 2021	Daniel Passeri	CHIEF EXECUTIVE OFFICER	3.40K	$14.72	$50.05K	BUY	6.54%	55.38K	Sep 24	View
Mar 17, 2021	Kenneth Pienta	CHIEF MEDICAL OFFICER	0.00	$10.05	-$135.70K	SELL-OPTIONS	0.00%	2.00K	Mar 15 - Mar 16	View
Feb 18, 2021	Kenneth Pienta	CHIEF MEDICAL OFFICER	0.00	$9.15	-$242.38K	SELL-OPTIONS	0.00%	2.00K	Feb 16 - Feb 17	View
Jan 22, 2021	Kenneth Pienta	CHIEF MEDICAL OFFICER	2.72K	$15.07	$40.98K	BUY	136.00%	4.72K	Jan 20	View
Nov 25, 2020	Aaron Fletcher	—	6.55K	$12.64	$82.78K	PURCHASE	3.91%	173.87K	Nov 24	View
Oct 01, 2020	Cameron Gray	—	10.00K	$15.15	$151.50K	PURCHASE	1.50%	677.50K	Sep 29 - Sep 30	View
Aug 07, 2020	Colin Sandercock	—	0.00	$13.75	-$165.93K	OPTION EXERCISE	0.00%	17.13K	Aug 05	View
Aug 07, 2020	Anish Suri	—	0.00	$13.21	-$10.87K	OPTION EXERCISE	0.00%	34.56K	Aug 05	View
Aug 05, 2020	Colin Sandercock	—	0.00	$13.75	-$82.84K	OPTION EXERCISE	0.00%	17.13K	Aug 03 - Aug 04	View
Aug 05, 2020	Anish Suri	—	0.00	$13.52	-$80.63K	OPTION EXERCISE	0.00%	34.56K	Aug 03 - Aug 04	View
Jun 25, 2020	Aaron Fletcher	—	7.50K	$24.88	$186.57K	PURCHASE	4.69%	167.32K	Jun 24	View
Dec 31, 2019	Christopher Marlett	DIRECTOR	-24.70K	$16.28	-$402.21K	SELL	-100.00%	0.00	Dec 27 - Dec 31	View
Dec 27, 2019	Christopher Marlett	DIRECTOR	-36.65K	$17.20	-$630.35K	SELL	-4.42%	793.20K	Dec 23 - Dec 26	View
Dec 19, 2019	Christopher Marlett	DIRECTOR	-276.73K	$15.94	-$394.11K	SELL	-25.01%	829.85K	Dec 12 - Dec 19	View
Jun 25, 2019	Daniel Passeri	CEO AND PRESIDENT	1.38K	$7.26	$10.00K	BUY	2.72%	51.98K	Jun 21	View
Jun 10, 2019	Colin Sandercock	SVP, GENERAL COUNSEL AND SEC	16.94K	$7.83	$132.66K	BUY	∞	16.94K	Jun 06 - Jun 10	View
Jun 07, 2019	Daniel Passeri	CEO AND PRESIDENT	3.00K	$6.90	$20.70K	BUY	6.30%	50.60K	Jun 06	View
Jan 04, 2019	Anthony DiGiandomenico	DIRECTOR	10.00K	$4.81	$48.10K	BUY	50.00%	30.00K	Dec 24	View
Jan 02, 2019	Christopher Marlett	DIRECTOR	18.52K	$4.64	$85.94K	BUY	1.70%	1.11M	Dec 31	View
Jan 02, 2019	Anthony DiGiandomenico	DIRECTOR	7.00K	$4.62	$32.34K	BUY	14.00%	57.00K	Dec 28	View
Dec 28, 2018	Anthony DiGiandomenico	DIRECTOR	20.00K	$4.77	$95.40K	BUY	66.67%	50.00K	Dec 27	View
Dec 27, 2018	Christopher Marlett	DIRECTOR	19.65K	$4.29	$84.29K	BUY	1.84%	1.09M	Dec 26	View
Dec 26, 2018	Anish Suri	CHIEF SCIENTIFIC OFFICER	2.00K	$4.37	$8.74K	BUY	∞	2.00K	Dec 21	View
Dec 26, 2018	Christopher Marlett	DIRECTOR	17.20K	$4.53	$77.92K	BUY	1.63%	1.07M	Dec 21	View
Dec 26, 2018	Anthony DiGiandomenico	DIRECTOR	10.00K	$4.49	$44.90K	BUY	100.00%	20.00K	Dec 21	View
Dec 21, 2018	Christopher Marlett	DIRECTOR	9.44K	$4.74	$44.74K	BUY	0.91%	1.05M	Dec 20	View
Dec 20, 2018	Christopher Marlett	DIRECTOR	400.00	$5.00	$2.00K	BUY	0.04%	1.04M	Dec 19	View
Dec 19, 2018	Christopher Marlett	DIRECTOR	3.66K	$5.20	$19.05K	BUY	0.35%	1.04M	Dec 18	View
Dec 18, 2018	Anthony DiGiandomenico	DIRECTOR	10.00K	$5.48	$54.80K	BUY	∞	10.00K	Dec 17	View
Dec 17, 2018	Christopher Marlett	DIRECTOR	10.00K	$5.06	$50.60K	BUY	0.97%	1.04M	Dec 13	View
Dec 13, 2018	Christopher Marlett	DIRECTOR	12.19K	$5.08	$61.98K	BUY	1.20%	1.03M	Dec 12	View
Dec 12, 2018	Christopher Marlett	DIRECTOR	7.54K	$4.86	$36.66K	BUY	0.74%	1.03M	Dec 11	View
Aug 29, 2018	Kerri-Ann Millar	VP-FINANCE	1.00K	$8.48	$8.48K	BUY	∞	1.00K	Aug 29	View
Aug 20, 2018	Daniel Passeri	CEO AND PRESIDENT	6.00K	$8.09	$48.51K	BUY	14.42%	47.60K	Aug 16	View
Jun 29, 2018	Daniel R Passeri	CEO AND PRESIDENT	1.60K	$11.97	$19.15K	BUY	4.00%	41.60K	Jun 29	View
Jan 19, 2018	Kenneth Pienta	CHIEF MEDICAL OFFICER	2.00K	$7.50	$15.00K	BUY	∞	2.00K	Dec 27	View

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.